Showing 1441-1450 of 3966 results for "".
Therapeutics Update: Notable Approvals in 2017
https://practicaldermatology.com/topics/skin-cancer-photoprotection/therapeutics-update-notable-approvals-in-2017/20398/A look at the newest additions to the medicine chest.Updates from CSF 2017
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-updates-from-csf-2017/18371/Dermatologists and core cosmetic physicians shared new insights and reviewed the developments in clinical and cosmetic dermatology at the ninth annual Cosmetic Surgery Forum in Las Vegas. Matthew Zirwas, MD addressed interest in oral supplements to support skin health. Neurotoxin pioneer Nick Lowe,eRelevance Uncovers Marketing Truths, EADV Data, Primetime for Botox
https://practicaldermatology.com/series/dermwire-tv/erelevance-uncovers-marketing-truths-eadv-data-primetime-for-botox/18429/The State of Aesthetic Healthcare Marketing 2017 from eRelevance shows that nearly 60 percent of aesthetic physicians say they either don't see results from their marketing initiatives or aren't able to measure results. Data presented at the annual meeting of the European Academy of Dermatology andRhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhofade-approved-sun-leaves-acne-behind-radiesse-turns-10/18552/The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking upThe Inside Scoop on Cosmeceuticals: From Top to Bottom
https://practicaldermatology.com/topics/general-topics/the-inside-scoop-on-cosmeceuticals-from-top-to-bottom/20896/Top derms dish about their favorite cosmeceuticals, including options beyond wrinkle fighting.New Products
https://practicaldermatology.com/columns/new-products/new-products/20961/Risk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHOR7 Tips to Expand Your Dermatology Social Network
https://practicaldermatology.com/topics/practice-management/7-tips-to-expand-your-dermatology-social-network/20967/Leverage the power of your social media accounts to generate more traffic for your dermatology practice.Assessing Dystrophic Nails: Finding the Cause
https://practicaldermatology.com/topics/general-topics/assessing-dystrophic-nails-finding-the-cause/21397/A podiatrist offers a unique perspective on the causes of dystrophic toenails.Hand-held and At-home Devices: Complementary or Competition?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hand-held-and-at-home-devices-complementary-or-competition/22958/It is incumbent upon dermatologists to recognize and potentially harness the benefits of at-home laser technologies.